Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-23 9:25 pm Unchanged | 2024-12-19 | 13D | Inventiva S.A. IVA | BIOTECHNOLOGY VALUE FUND L P | 8,545,499 9.000% | 0 (Unchanged) | Filing History |
| 2024-11-13 12:26 pm Purchase | 2024-09-30 | 13G | Inventiva S.A. IVA | Yiheng Capital Partners, L.P. | 4,331,196 8.310% | 1,686,270 (+63.75%) | Filing History |
| 2024-10-21 9:00 pm Unchanged | 2024-10-17 | 13D | Inventiva S.A. IVA | BIOTECHNOLOGY VALUE FUND L P | 8,545,499 9.800% | 0 (Unchanged) | Filing History |
| 2024-10-21 8:54 pm Purchase | 2024-10-17 | 13D | Inventiva S.A. IVA | New Enterprise Associates 17, L.P. | 7,835,884 9.000% | 2,262,931 (+40.61%) | Filing History |
| 2024-07-19 4:30 pm Unchanged | 2024-07-17 | 13D | Inventiva S.A. IVA | BIOTECHNOLOGY VALUE FUND L P | 8,545,499 16.300% | 0 (Unchanged) | Filing History |
| 2024-05-03 9:22 pm Purchase | 2024-04-03 | 13D | Inventiva S.A. IVA | New Enterprise Associates 17, L.P. | 5,572,953 10.700% | 420,920 (+8.17%) | Filing History |
| 2024-02-14 4:08 pm Unchanged | 2023-12-31 | 13G | Inventiva S.A. IVA | Yiheng Capital Partners, L.P. | 2,644,926 6.280% | 0 (Unchanged) | Filing History |
| 2024-02-09 4:49 pm Purchase | 2023-12-31 | 13G | Inventiva S.A. IVA | Sofinnova Crossover I | 6,110,827 9.700% | 2,728,888 (+80.69%) | Filing History |
| 2023-09-25 4:35 pm Purchase | 2023-08-31 | 13D | Inventiva S.A. IVA | BIOTECHNOLOGY VALUE FUND L P | 8,545,499 16.500% | 587,361 (+7.38%) | Filing History |
| 2023-09-05 4:58 pm Purchase | 2023-08-30 | 13G | Inventiva S.A. IVA | Qatar Investment Authority | 5,157,233 9.970% | 5,157,233 (New Position) | Filing History |
| 2023-02-14 4:08 pm Purchase | 2022-12-31 | 13G | Inventiva S.A. IVA | Yiheng Capital Partners, L.P. | 2,644,926 6.470% | 2,644,926 (New Position) | Filing History |
| 2023-02-13 2:07 pm Purchase | 2022-12-31 | 13G | Inventiva S.A. IVA | Sofinnova Crossover I | 3,381,939 8.000% | 129,032 (+3.97%) | Filing History |
| 2022-02-11 12:00 pm Purchase | 2021-12-31 | 13G | Inventiva S.A. IVA | Sofinnova Crossover I | 3,252,907 6.200% | 138,880 (+4.46%) | Filing History |
| 2021-02-10 4:15 pm Purchase | 2020-12-31 | 13G | Inventiva S.A. IVA | Broqua Pierre | 3,882,500 10.100% | 3,882,500 (New Position) | Filing History |
| 2021-02-10 4:15 pm Purchase | 2020-12-31 | 13G | Inventiva S.A. IVA | Cren Frederic | 5,612,224 14.600% | 5,612,224 (New Position) | Filing History |
| 2021-02-08 7:30 pm Purchase | 2020-12-31 | 13G | Inventiva S.A. IVA | Sofinnova Crossover I | 3,114,027 10.400% | 3,114,027 (New Position) | Filing History |
| 2020-07-21 3:38 pm Purchase | 2020-07-15 | 13D | Inventiva S.A. IVA | New Enterprise Associates 17, L.P. | 5,152,033 13.500% | 5,152,033 (New Position) | Filing History |
| 2020-07-20 4:22 pm Purchase | 2020-07-10 | 13D | Inventiva S.A. IVA | BIOTECHNOLOGY VALUE FUND L P | 7,958,138 20.700% | 7,958,138 (New Position) | Filing History |